2. Signaling Pathways
  3. Metabolic Enzyme/Protease
  4. Liposome

Liposome

Liposomes (NPs typically 100–500 nm in diameter) are fabricated from the self-assembly of phospholipids, which consist of a polar phosphate head group and hydrophobic lipid tails. In aqueous environments, the hydrophobic tails self-orient, resulting in a spherical structure comprised of an aqueous core surrounded by a lipophilic bilayer membrane. Liposomes are both biocompatible and biodegradable (e.g., at certain pH and temperature), which can be controlled by modifying the lipid composition. Furthermore, liposomes are amenable to various modifications that improve their efficacy as drug delivery carriers.

Liposome Related Products (839):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-158861
    C3-K2-E14
    		98.5%
    C3-K2-E14 is a multi-ionizable amino-lipid featuring a central tertiary amine with two identical branches and an n-propyl group. Each branch features a propanamide linking to a branched amine, each with two C14 arms and a hydroxyl. Ionizable lipids such as this may be applied in the development of lipid nanoparticles for drug discovery.
    C3-K2-E14
  • HY-143691
    MGlc-DAG
    		99.84%
    MGlc-DAG, a glycoglycerolipid, can be used for the synthesis of drug delivery compound.
    MGlc-DAG
  • HY-W440919
    DSPE-PEG-Rhodamine, MW 2000
    DSPE-PEG-Rhodamine, MW 2000 is a dye functionalized phospholipid. The amphiphilic polymer can form lipid bilayer in water and be used to encapsulate therapeutic agents, such as liposomal anticancer drug or mRNA vaccine. Rhodamine has maximum absorption at 570 nm and emission around 595 nm and can be easily traced using an imaging technique.
    DSPE-PEG-Rhodamine, MW 2000
  • HY-159709
    VL-422
    VL-422 is an ionizable cationic lipid that can be used for lipid nanoparticle (LNP) and drug delivery research.
    VL-422
  • HY-159735
    Lipid 23
    		99.30%
    Lipid 23 is an ionizable cationic amino lipid that can be used to generate lipid nanoparticles (LNP). Lipid 23 can be used for mRNA delivery.
    Lipid 23
  • HY-157252
    CL4F8-6
    		99.80%
    CL4F8-6 is an ionizable cationic lipid with a pKa of 6.14. CL4F8-6 can be used in lipid nanoparticles (LNPs)-based mRNA therapeutics.
    CL4F8-6
  • HY-W040193S4
    DSPC-d4
    		99.0%
    DSPC-d4 (1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d4) is the deuterium labeled DSPC (HY-W040193). DSPC is a cylindrical-shaped lipid. 1,2-Distearoyl-sn-glycero-3-phosphorylcholine is used to synthesize liposomes, and is the lipid component in the lipid nanoparticle (LNP) system.
    DSPC-d<sub>4</sub>
  • HY-172688
    DSPE-PEG5000-CSTSMLKAC
    DSPE-PEG5000-CSTSMLKAC is a PEG compound which composed of DSPE and a peptide (CSTSMLKAC). CSTSMLKAC is capable of mediating selective homing of phage to ischemic heart tissue. DSPE-PEG5000-CSTSMLKAC can be used for drug delivery.
    DSPE-PEG5000-CSTSMLKAC
  • HY-134541S6
    SM-102-d4
    SM-102-d4 is the deuterium labeled SM-102 (HY-134541). SM-102 is an amino cationic lipid useful in the formation of lipid nanoparticles (LNPs). SM-102 has higher transfection efficiency. SM-102 plays an important role in the effectiveness of lipid nanoparticles (LNPs) in delivering mRNA therapeutics and vaccines.
    SM-102-d<sub>4</sub>
  • HY-144017
    12:0 EPC chloride
    12:0 EPC chloride is a cationic phospholipid. 12:0 EPC chloride can be used for drug delivery.
    12:0 EPC chloride
  • HY-W440928
    Stearic acid-PEG-NHS (MW 3400)
    DSPE-PEG-DBCO, MW 5000 is a phospholipid polyPEG which can self-assemble in water to form lipid bilayer. The polymer can be used to prepare liposomes as drug carrier to deliver nutrients/therpeutic agents, such as mRNA or DNA. Reagent grade, for research use only.
    Stearic acid-PEG-NHS (MW 3400)
  • HY-147207C
    Phospholipid-PEG-Biotin (MW 5000)
    Phospholipid-PEG-Biotin (MW 5000) is a phospholipid PEG derivative, can be used for modify liposome and cells surface, and pancreatic islets for cell transplantation. Phospholipid is a class of lipid containing a hydrophilic “head” and two hydrophobic “tails”; PEG is a hydrophilic and water-soluble polymer with low toxicity; Biotin is an enzyme co-factor, can be used for labeling protein.
    Phospholipid-PEG-Biotin (MW 5000)
  • HY-172723A
    DSPE-PEG3400-T7
    DSPE-PEG3400-T7 is a PEG compound which composed of DSPE and a transferrin receptor (TfR) peptide (T7). T7 (HAIYPRH) specifically binds to TfR (transferrin receptor). DSPE-PEG3400-T7 can be used for drug delivery.
    DSPE-PEG3400-T7
  • HY-W440681
    C13-112-tri-tail
    C13-112-tri-tail is a cationic lipid-like compound containing a polar amino alcohol head group, three hydrophobic carbon-13 tails, and a PEG2 linker. C13-112-tri-tail can be formulated into a lipid nanoparticle (LNP).
    C13-112-tri-tail
  • HY-147207D
    Phospholipid-PEG-Biotin (MW 10000)
    Phospholipid-PEG-Biotin (MW 10000) is a phospholipid PEG derivative that has a biotin and a phospholipid bridged by a linear PEG linker. Phospholipid-PEG-Biotin (MW 3400) can interact with avidinylated antibodies. Phospholipid-PEG-Biotin (MW 3400) can be used to modify liposome and cells surface, and pancreatic islets for cell transplantation.
    Phospholipid-PEG-Biotin (MW 10000)
  • HY-142987
    Linoleyl methane sulfonate
    Linoleyl methane sulfonate is a selective lipid-based vehicle for use in drug delivery systems.
    Linoleyl methane sulfonate
  • HY-172270D
    DSPE-PEG5000-Mal-Cys-KTLLPTP
    DSPE-PEG1000-PTP is synthesised by conjugating the amino group of plectin-1 peptide (PTP) with DSPE-PEG-NHS ester via amide bonds. DSPE-PEG1000-PTP can be used to construct drug delivery vectors.
    DSPE-PEG5000-Mal-Cys-KTLLPTP
  • HY-172468
    DSPE-PEG5000-CTT2
    DSPE-PEG5000-CTT2 is a PEG compound which composed of DSPE and a gelatinase inhibitor (CTT2 (CTTHWGFTLC)). CTT2 (CTTHWGFTLC) has the ability to specifically target tumors. DSPE-PEG5000-CTT2 can be used for drug delivery.
    DSPE-PEG5000-CTT2
  • HY-W127331
    Cholesterol hexanoate
    Cholesterol hexanoate is an organic compound belonging to the class of esters. It is formed from the reaction between cholesterol and caproic acid. Cholesterol hexanoate has several applications in the pharmaceutical industry, particularly as a bioactive compound with potential research potential for improving a range of medical conditions, such as high cholesterol and inflammation-related diseases. Additionally, it has potential applications as a food additive to improve texture and stability.
    Cholesterol hexanoate
  • HY-144012A
    DPPE-PEG350
    DPPE-PEG350 is a CD1d-dependent lipid antagonist thus blocking the ERK phosphorylation pathway in iNKT cells. DPPE-PEG350 is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles.
    DPPE-PEG350